COMMUNIQUÉS West-GlobeNewswire

Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
09/05/2025
Reports first quarter 2025 total revenue of $7.2 million , representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter [...]
Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series
09/05/2025
WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
09/05/2025
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces [...]
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
09/05/2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its [...]
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
09/05/2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 [...]
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
09/05/2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data [...]
InspireMD Reports First Quarter 2025 Financial Results
09/05/2025
Management to host investor conference call today, May 9th, at 8:30am ET MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of [...]
Vireo Growth Inc. Announces First Quarter 2025 Results
09/05/2025
– Q1 revenue of $24.5 million increased 1.9% year-over-year, in line with expectations for Vireo’s established markets – – Merger Transactions expected to begin closing in Q2 and further strengthen profitability profile [...]
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
09/05/2025
FRIENDSWOOD, Texas, May 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the first [...]
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
09/05/2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
09/05/2025
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4% Total Rare Disease quarterly net revenues of $69.0 million, which includes: Purified Cortrophin® Gel net revenues of [...]
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
09/05/2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]
Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025
09/05/2025
Oral dual-targeted ABCB4/BSEP positive functional modulator (PFM) improved cholestatic and cholangitis markers in orthogonal models of hepatobiliary disease Data reinforce the potential of this differentiated mechanism [...]
Sanuwave Announces Q1 FY2025 Financial Results
09/05/2025
Q1 2025 revenues were $9.3 million , up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0% , versus 72.6% in Q1 2024. GAAP Operating [...]
Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting
09/05/2025
First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI [...]
RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025
09/05/2025
LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Florida Governor Ron DeSantis Joins Olympia Pharmaceuticals in Ribbon-Cutting Ceremony for New Sister Pharmacy, Wesley Pharmaceuticals
09/05/2025
The new Orlando-based 503B pharmacy plans to hire 100 Floridians this year while reducing medication costs and increasing transparency for consumers ORLANDO, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals [...]
Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
09/05/2025
Net Income of $3.7 million; reaffirms Full-Year Revenue Guidance of $118–$128 million Q1 2025 revenue of $22.1 million; GAAP basic EPS: $0.03 Completed data collection and achieved database lock for the pivotal Phase 3 [...]
Sumatra Slim Belly Tonic Reviews: What Users Are Saying About This Blue Tonic for Weight Loss
09/05/2025
HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight today can feel like a bigger challenge than ever before. Despite trying endless diets, workout plans, and the latest supplements, many of us still struggle with [...]

Pages